Authors:
Granziero, L
Ghia, P
Circosta, P
Gottardi, D
Strola, G
Geuna, M
Montagna, L
Piccoli, P
Chilosi, M
Caligaris-Cappio, F
Citation: L. Granziero et al., Survivin is expressed on CD40 stimulation and interfaces proliferation andapoptosis in B-cell chronic lymphocytic leukemia, BLOOD, 97(9), 2001, pp. 2777-2783
Authors:
Bertero, MT
De Maestri, M
Caligaris-Cappio, F
Citation: Mt. Bertero et al., Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma, HAEMATOLOG, 85(2), 2000, pp. 216-217
Citation: P. Ghia et F. Caligaris-cappio, The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms, ADV CANC R, 79, 2000, pp. 157-173
Citation: F. Caligaris-cappio et Tj. Hamblin, B-cell chronic lymphocytic leukemia: A bird of a different feather (vol 17, pg 399, 1999), J CL ONCOL, 17(3), 1999, pp. 1092-1092
Authors:
Stacchini, A
Aragno, M
Vallario, A
Alfarano, A
Circosta, P
Gottardi, D
Faldella, A
Rege-Cambrin, G
Thunberg, U
Nilsson, K
Caligaris-Cappio, F
Citation: A. Stacchini et al., MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation, LEUK RES, 23(2), 1999, pp. 127-136
Authors:
Alfarano, A
Circosta, P
Vallario, A
Camaschella, C
Indraccolo, S
Amadori, A
Caligaris-Cappio, F
Citation: A. Alfarano et al., Alternative splicing of CD79a (Ig alpha) and CD79b (Ig beta) transcripts in human B-CLL cells, CURR T MICR, 246, 1999, pp. 241-248
Authors:
Alfarano, A
Indraccolo, S
Circosta, P
Minuzzo, S
Vallario, A
Zamarchi, R
Fregonese, A
Calderazzo, F
Faldella, A
Aragno, M
Camaschella, C
Amadori, A
Caligaris-Cappio, F
Citation: A. Alfarano et al., An alternatively spliced form of CD79b gene may account for altered B-cellreceptor expression in B-chronic lymphocytic leukemia, BLOOD, 93(7), 1999, pp. 2327-2335
Authors:
Zwierzina, H
Caligaris-Cappio, F
Connors, T
D'Incalci, M
Double, J
Hendriks, H
Leake, R
Newell, H
Willemze, R
Wilmanns, W
Citation: H. Zwierzina et al., Organization of preclinical and clinical research on anticancer therapy with biological response modifiers (BRMs), BIOM HLTH R, 24, 1998, pp. 240-244